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Burkitt lymphoma (BL) is a high grade B cell malignancy
(Non-Hodgkin Lymphoma (NHL)) derived from germi-
nal center B cells (GCB) that harbours a chromosomal
translocation juxtaposing the protooncogene MYC next to
the regulatory elements of one of the immunoglobulin
loci. However, the precise contribution of Myc to the
pathogenesis of this tumour is poorly understood. Based
on the definition of a distinguishing gene expression sig-
nature for the molecular BL (mBL) with Myc as one hall-
marking signature gene we are interested in getting
answers to the questions (i) what are the target genes of
Myc in primary human GCB cells and (ii) what is the func-
tional significance of signature genes identified?
We describe a non-viral vector based approach (Vockerodt
et al. 2008) to express Myc in primary human GCB cells.
Comparative gene expression profiling was performed
accompanied by qRT-PCR. In addition elucidation of the
function of selected signature genes in BL is accom-
plished. In a representative cell line with a mBL signature
RNAi directed inhibition of elements of the CD40 signal-
ing cascade was conducted. After activating this particular
signaling cascade in a BL cell line we analysed respective
gene expression profiles of IKKa, IKKb, TRAF2, TRAF6,
Jak3, BCL-3 and p38 deficient cells. Based on these differ-
ent RNAi-mediated GE-profiles we reconstruct the topol-
ogy of the respective signaling pathway by using the
nested effects bioinformatic model, which has been
described recently (Markowetz et al. 2005).
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